FDA Commissioner Scott Gottlieb. Photo: Chip Somodevilla/Getty Images

The partial government shutdown is beginning to cramp the Food and Drug Administration’s ability to review new drugs, and those effects will only grow more pronounced if the shutdown continues to drag on.

Driving the news: Aimmune Therapeutics, a company that’s seeking approval for a new drug to help children with peanut allergies, said in a financial filing yesterday that the FDA won’t be able to review its product until the government reopens.

How it works: Aimmune's product is an outlier — the FDA can only review allergy drugs when Congress provides funding. For other types of drugs, pharmaceutical companies pay the FDA a fee when they submit new products for approval, and those fees fund the review process.

  • But those products could also feel a squeeze, because the FDA can’t accept new fees or applications during the shutdown.
  • FDA commissioner Scott Gottlieb said yesterday the agency has moved some money around and can keep the review process going for roughly another five weeks.

What’s next: Several drugs could be left hanging in the balance if the FDA reaches the end of that five-week "runway" and the government is still shut down, STAT reports.

  • They include a potential depression treatment from Janssen Pharmaceuticals, a diabetes drug from Sanofi, and a multiple sclerosis drug from Novartis.
  • If the shutdown continues, it could also create a backlog of reviews that would affect drugs slated for an approval decision later this year, STAT reports, including an HIV/AIDS drug.

On the bright side, the FDA will resume its inspections of high-risk food processing plants, using unpaid inspectors.

Go deeper: All the ways Americans are feeling the effects of the shutdown

Editors' note: This story has been updated to clarify that the FDA's review of Aimmune's product would not be covered by industry fees.

Go deeper

Updated 35 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 5 p.m. ET: 12,382,748 — Total deaths: 557,241 — Total recoveries — 6,796,045Map.
  2. U.S.: Total confirmed cases as of 5 p.m. ET: 3,163,505 — Total deaths: 133,847 — Total recoveries: 969,111 — Total tested: 38,032,966Map.
  3. Public health: The reality of the coronavirus bites.
  4. Trade: Trump says he's no longer considering phase-two trade deal with China because the pandemic damaged the two countries' relationship.
  5. 🎧 Podcast: Rural America has its own coronavirus problem.
39 mins ago - Health

Reality of the coronavirus bites

National Airport in D.C. Photo: Daniel Slim/AFP/Getty Images

It feels like mid-March in America again. The coronavirus is surging, deaths are climbing and the country is dreading a wave of disruptions, less than four months since the first round started.

The big picture: Lingering under all the happy talk of future plans is the reality of this virus — which thrives in potential super-spreader conditions like mass gatherings.

2 hours ago - Podcasts

Rural America has its own coronavirus problem

It's often easier to socially distance in rural America, but it can simultaneously be more challenging to get medical care.

Axios Re:Cap digs into the pandemic's urban-rural divide with microbiologist Amber Schmidtke, who has found that coronavirus-related morbidity is higher in many of Georgia's rural counties than in Atlanta.